Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
constipation
CJ Lau
26 Aug 2009
Outline
Definition of constipation
Etiology and pathophysiology of
constipation
Rationale for drug use
Pharmacological and non pharmacological
treatments
Patient education/counselling
Definition
Constipation has varied meaning for
different people
Rome II criteria define constipation as >2
of the following in a 12 weeks period:
1. Straining at defecation at least a quarter
of the time
2. Lumpy or hard stools at least a quarter of
the time
3. Sensation of incomplete evacuation at
least a quarter of the time
4. 3 or fewer bowel movements/week
Types of constipation
Acute constipation
1. Use suppositories or enema to clear the rectum and
followed by simple non drug measure
2. Use lactulose or sorbitol if dietary fibre cannot be
adequately increased
Fecal impaction
1. Occurs when dry hard stool become compacted into large
hard stool which cannot be expelled from rectum
Fecal impaction
continues..
2. Should initially be disimpacted by manual disimpaction
3. An enema with mineral oil can then be used to soften
the stool
4. Sometimes impacted fecal must be accomplished using
sigmoidoscopy with instrumentation
5. Regular laxative use in addition to lifestyle and diet
changes
Types of constipation
Chronic constipation
1. Normal colonic transit- exhibit psychosocial
distress
2. Colonic inertia/slow colonic transit- have
delayed passage of radiopaque markers
through proximal colon, have little or no
increase in motor activity following a meal
3. Dyssynergic defecation- inappropriate
contraction of pelvic floor muscle, can be only
diagnosed with anorectal manometry
Etiology
The slowing of colonic transit may be
idiopathic or due to motor disorders
associated with many diseases
Due to side effects of many drugs- opiods,
calcium supplements, verapamil,
anticholinergics, aluminium antacids
Medical conditions (secondary causes)-
hypothyroidism, pregnancy, irritable
bowel syndrome, Parkinson disease, colon
cancer & Hirschprung’s disease
Pathophysiology
Defecation involves the coordinated relaxation
of puborectalis and external anal sphincter
muscles, together with increased in
intraabdominal pressure and inhibition of colonic
segmenting activity.
Slow transit constipation- possibly related to
decreased numbers of high-amplitude
propagated contractions
Pelvic floor dysfunction- features normal or
slightly slowed colonic transit, leads to inability
to evacuate adequately the content from the
rectum.
Hirschsprung’s disease
Incidence of 1 in 5000 patients, commonly due to
trisomy 21
A rare cause of intractable constipation in toddler
and children
Absence of ganglion cells in the myenteric &
subcutaneous plexures of the distal colon resulting
sustained contraction of the aganglionic segment.
Bowel above the constricted area dilates
(megacolon) due to stool trapping
Commonly occurs near rectum region
May require surgery to remove the aganglion
segment
Evaluation/diagnosis
Careful history taking- defining the
nature and duration of constipation and
identify secondary causes
Physical examination- rectal examination
may be helpful. It can identify fissures
and heamorrhoids
Endoscopy/colonoscopy
Radiography/imaging
Dietary and lifestyle
changes
Is the mainstay treatment for constipation, it should
be continued even when laxatives are used
Ensure adequate dietary fibre intake (25-30g/daily).
Increase intake gradually to avoid bloating &
flatulence
Ensure adequate fluid intake
Increase exercise, avoid sedentary lifestyle
Behaviour changes- do not hold urge to defecate
When to start treatment
Symptoms do not resolve after
treating reversible causes (eg.
Hypothyroidism, depression etc)
Dietary changes are ineffective
Fecal impaction
When starting on opioid analgesia
Onset of effect of
Group of laxatives
Examples Onset of
laxatives action
Bulking pysllium Oral: 48-
agents 72hours
Osmotic Glycerol, Oral: 24-
laxatives lactulose, 72hours
sorbitol Rectal: 5-
30min
Polyethylene Oral: 0.5-
glycol, saline 3hours
laxatives Rectal: 2-
30min
Stool softener Docusate, Oral: 24-
Bulking agent (eg.
psyllium)
Useful for mild constipation,small hard stool
and long term control
Not to be used in acute constipation
Absorb water into colon to increase fecal
bulk which stimulates peristaltic activity
Ensure adequate fluid intake to avoid
intestinal obstruction
Pregnancy risk factor B & excretion in breast
milk unknown
S/E: flatulence, bloating, abdominal
discomfort
Osmotic laxatives
Glycerol (suppository)- can be used for acute relief of
constipation, onset of action (5-30minutes)
1. Ravin enema (List C item) is available in hospital,
contains glycerin 25% and NaCl 15%
Lactulose (List B item, available as 3.35g/5ml in hospital)
1. not suitable for acute relief (onset of action-1 to 3 days),
need to be taken regularly
2. Poorly absorbed, metabolised by colonic bacteria, exert
osmotic effect on colon
3. CI- lactose and galactose intolerance
4. Dose- adult: 15-30ml/day, increase to 60ml/day in 1-2
divided dose, paed: 0.5ml/kg 12-24hourly
5. Pregnancy risk factor B and excretion in breast milk
unknown
6. Can be mixed with water, fruit juice or milk for better
taste
Osmotic laxatives
Sorbitol 70%
1. non absorbable sugar, produce osmotic effect at the colon
2. Dose: 2-11yo – 2ml/kg , >12yo- 30-150ml
3. Precaution- use with caution with patients with severe
cardiopulmonary or renal impairment, large volume may
cause fluid overload or electrolytes imbalance
4. S/E: oedema, abdominal discomfort, diarrhea, fluid and
electrolytes disturbances
Osmotic laxatives
Polyethylene glycol
1. Used for bowel cleansing prior to GI
examination or occasional treatment of
constipation
2. Dose for constipation: adult- 17g of
powder dissolves in 8oz(240ml) of water
for Miralax, not to be used for > 2 weeks
3. Do not add flavouring agent to the
solution, chilled solution is more palatable
4. Many commercial dosage forms available,
dose depends on each product (eg.
Movicol, Movicol half, Colonlytelly)
Osmotic laxatives
Saline laxatives
1. Contains poorly absorbed irons eg magnesium sulfate,
phosphate, and citrate which retain water in colon by
osmotic effect and stimulates peristalsis
2. Onset of action- 30min to 3hours
3. Sodium phosphate laxatives are CI in heart failure and
renal impairment
4. Dosage- depending on each product
5. S/E: nausea, bloating, electrolyte imbalance
6. Eg- Fleet Ready-to-use Enema®, Micolette®, Microlax®,
Stool softener
Have little value used as single agent in chronic
constipation or opiod induced constipation
Liquid paraffin (List C item)
1. Lubricates fecal material to facilitate passage
2. CI in children <3yo, pregnancy, bed ridden patients
3. Dose- 10-30ml in adults, 1ml/kg daily
4. S/E: rectal leakage and anal irritation
5. Do not take a dose immediately before lying down to
prevent aspiration
Stool softener
Docusate
1. Used for constipation associated with dry hard stools and for avoiding
straining
2. Facilitate admixture of fat and water to soften stool
3. Onset of action- 24-72hours
4. Dosage (oral):
-children 3-6 yo, 10-40mg/day in 1-4 divided dose
-children 6-12yo, 40-150mg/day in 1-4 divided dose
-adults, 50-500mg/day in 1-4 divided dose
5. Available in capsule, syrup, enema form
Stimulant laxatives
Act by direct stimulation at nerve ending in colonic
mucosa to increase intestinal motility
CI in intestinal obstruction or inflammatory bowel
syndrome as it often causes abdominal cramp
S/E: abdominal discomfort, cramp, nausea, diarrhoea,
fluid & electrolyte imbalance with prolonged use
May be use in long term for constipation associated with
spinal damage, chronic neuromuscular disease and in
people taking opioid
Stimulant laxatives
Bisacodyl
1. Available in hospital as 5mg tablet and 5mg & 10mg
suppository
2. Onset of action- 15min to 1 hr (suppository), 6 to
12hr (oral)
3. Dose (Oral): >10yo, 10mg at night
children 4-10yo, 5mg at night
4. Dose (supp): <10yo, 5mg morning
>10yo, 10mg morning
Senna
1. Onset of action- 6-12hr
2. S/E: discolouration of urine to yellowish brown or red.
3. Dose: 7.5-30mg at bedtime for adults
4. Available in market as tablet, granule
Non pharmacological
treatment
Biofeedback
1. Behavioral approach that is used to correct
inappropriate contraction of the pelvic floor
muscles and external anal sphincter during
defecation
2. Train patients to relax pelvic floor muscles
during straining and to correlate relaxation and
pushing during defecation
3. Does not appear to benefit patients with slow
transit constipation
4. Evidence quality is moderate
Overall Management
Normal or slow transit constipation-
patient education, dietary changes,
drug therapy, behavioral therapy
Severe intractable slow transit
constipation- surgery in extreme
condition
Dyssynergic defecation- biofeedback
References
Tramonte, SM, Brand, MB, Mulrow, CD, et al. The treatment
of chronic constipation in adults. A systematic review. J Gen
Intern Med 1997; 12:15.
Floch, MH, Wald, A. Clinical evaluation and treatment of
constipation. Gastroenterologist 1994; 2:50
Longstreth, GF, Thompson, G, Chey, WD, et al. Functional
bowel disorders Gastroenterology 2006; 130:1480
An Evidence-Based Approach to the Management of Chronic
Constipation in North America. Am J Gastroenterol 2005;
100:S1
Chiarioni, G, Whitehead, WE, Pezza, V, et al. Biofeedback is
superior to laxatives for normal transit constipation due to
pelvic floor dyssynergia. Gastroenterology 2006; 130:657.
Lexi-comps drug information handbook 13th ed
Australian medicine handbook 2008
BNF and BNF for children online
Frank Shann 14th ed